Cofactor restoration → tissue repair → GH-axis (post-weaning)

Postpartum Recovery

3 phases4 peptidesRelated goal hub →Related life-stage hub →

This protocol covers the postpartum recovery window — the months after birth, when nutrient stores are depleted, tissue is healing, sleep is fragmented, and body composition needs are different from any other life stage. It is structured around a load-bearing safety distinction: PHASE 1 (B12 + B-complex cofactor restoration) is SAFE to run while breastfeeding; PHASE 2 (BPC-157 tissue repair) and PHASE 3 (CJC/Ipa GH-axis) are NOT — those peptides have no human breastfeeding safety data and should be deferred until weaning is complete.

The protocol is NOT a substitute for postpartum clinical care. Your OB-GYN or midwife is the gatekeeper for any wound healing concerns (C-section incision, perineal repair), pelvic floor recovery (where pelvic floor PT is often the better answer than any peptide), thyroid screening (postpartum thyroiditis affects ~5-10% of births), and depression screening (postpartum depression affects ~10-20% of births and needs standard care — therapy + sertraline as breastfeeding-compatible first-line SSRI).

If you have any of the following, this protocol is NOT the answer: ongoing postpartum hemorrhage or unexplained bleeding (medical emergency); active postpartum depression or suicidal ideation (call 988 / get crisis care; PPD has effective standard treatment); active infection or wound dehiscence (your OB-GYN); ongoing breastfeeding difficulty (lactation consultant + pediatrician).

Phases

Phase 1 — Cofactor restoration (B12 + B-complex)
weeks 1-8 postpartum (SAFE during breastfeeding)
Pregnancy + breastfeeding deplete B-vitamin stores; most postpartum users are nutrient-depleted even with prenatal supplementation. B12 1000mcg SubQ weekly + monthly B-complex injection (compounded, B6-conservative formulation) addresses the underlying cofactor depletion that drives a significant fraction of postpartum fatigue + cognitive fog. SAFE during breastfeeding — both B12 and standard B-complex doses transfer to breast milk at concentrations that benefit the infant (B12 deficiency in breastfed infants of B12-deficient mothers is the more relevant safety concern).
- B12 (Methylcobalamin)1 mg · once weekly · morning
  1000mcg SubQ once weekly. Methylcobalamin is the bioavailable form preferred for postpartum repletion (some users have functional MTHFR variants that slow conversion of cyanocobalamin). Safe during breastfeeding; B12 transfers to breast milk and benefits infant B12 status.
- B-Complex (Injectable)1 mg · every 4 weeks · morning
  Standard compounded B-complex IM/SubQ, monthly. Verify the formulation has B6 ≤25-50mg per dose — high-dose B6 (>100mg) carries sensory neuropathy risk with chronic use and is unnecessary for routine repletion. Postpartum is one of the more clearly-evidenced indications for parenteral B-complex (Tier 1-2 for the deficiency-replacement use case, in contrast to Tier 4 for 'energy boost' marketing in B-replete users).
What “working” looks like
Modest energy improvement over 4-6 weeks. Less cognitive fog. Mood baseline supported (B-vitamin deficiency commonly presents with low-grade mood symptoms — addressing it doesn't treat PPD but does remove a confounding contributor). Sleep quality not changed (sleep fragmentation is infant-driven, not cofactor-driven). No body composition changes (that's Phase 3).
Decision criteria
After 8 weeks: review symptoms and overall picture. If meaningful improvement, this is your working protocol — continue Phase 1 throughout breastfeeding. If symptoms persist or worsen, this is the moment to check for: (a) thyroid (postpartum thyroiditis — pull TSH, free T4, TPO antibodies); (b) iron + ferritin (postpartum iron deficiency is very common, especially with hemorrhage history); (c) PPD screening with your OB-GYN. Phase 2+3 are NOT options while breastfeeding regardless of Phase 1 outcome.
Labs to pull
- B12 (serum + MMA if symptoms persist with normal-range serum value)
- Folate (RBC folate is more sensitive than serum)
- CBC + ferritin + iron studies (postpartum iron deficiency is common; ferritin <30 ng/mL warrants iron repletion regardless of CBC)
- TSH + free T4 + TPO antibodies (postpartum thyroiditis screen — affects 5-10% of births, often missed)
- 25-OH vitamin D (commonly deficient postpartum)
Phase 2 — Tissue repair (+BPC-157) — POST-WEANING ONLY
weeks 8-12 of this phase, after breastfeeding complete
HARD GATE: this phase is NOT for users who are still breastfeeding. BPC-157 has no human pregnancy or breastfeeding safety data; transfer to breast milk and effects on a nursing infant have not been characterized. Defer until weaning is fully complete. For post-weaning users with residual tissue-recovery concerns — C-section abdominal wall healing, perineal recovery from significant tearing, diastasis recti not fully resolving — BPC-157 250mcg SubQ daily provides community-experience support for tissue repair. The rodent tissue-repair evidence is consistent; human evidence is limited to small uncontrolled case series. Continue Phase 1 B12 + B-complex throughout.
- B12 (Methylcobalamin)1 mg · once weekly · morning
  Continue Phase 1 cofactor.
- B-Complex (Injectable)1 mg · every 4 weeks · morning
  Continue Phase 1 cofactor.
- BPC-157250 mcg · once daily · morning
  250mcg SubQ once daily — middle of community range; conservative for post-weaning use. For C-section scar work, can inject near the scar; for perineal recovery, systemic SubQ is the practical route (local injection is not advised for that anatomy). Cycle 4-8 weeks on, then re-evaluate — community practice is not to run BPC continuously beyond ~30 days without a break.
What “working” looks like
C-section scar tissue softens / mobility improves over 4-8 weeks. Lingering perineal discomfort eases. Diastasis recti changes are NOT BPC-driven (those need pelvic floor PT + targeted exercise; BPC supports tissue but doesn't close the rectus separation). No measurable lab change — this is a subjective tissue-quality signal.
Decision criteria
After 8 weeks: if tissue quality has clearly improved, taper off and re-engage only if specific tissue concerns recur (long-term continuous BPC use beyond ~30 days has no human safety data). If no improvement, pelvic floor PT and OB-GYN follow-up are higher-leverage than continuing BPC.
Phase 3 — GH-axis body comp recovery (+CJC/Ipa) — POST-WEANING + 3+ MONTHS
weeks 12+, starting 3+ months post-weaning
HARD GATE: this phase is NOT for users who are still breastfeeding. Additionally, even for post-weaning users, defer at least 3 months after weaning is complete to allow physiologic recovery + cycle return + thyroid normalization before adding GH-axis stimulation. CJC/Ipa 250/250mcg SubQ 5 days/week before bed (fasted 2+ hours) addresses body-composition recovery — sleep quality (GH peaks in slow-wave sleep, which the protocol now allows to happen uninterrupted), visceral fat redistribution, lean-mass support, recovery from training as users re-engage with exercise.
- B12 (Methylcobalamin)1 mg · once weekly · morning
  Continue Phase 1 cofactor.
- B-Complex (Injectable)1 mg · every 4 weeks · morning
  Continue Phase 1 cofactor.
- BPC-157250 mcg · once daily · morning
  Continue Phase 2 dose if still actively addressing tissue concerns. Optional in Phase 3 if Phase 2 tissue work is complete.
- CJC-1295 / Ipamorelin250 mcg · 5 days per week · before bed, fasted 2+ hours
  10 units SubQ (250mcg CJC + 250mcg Ipa) 5 days/week before bed, fasted 2+ hours. Insulin from a recent meal blunts the ghrelin-pathway response, so dose fasted. Standard community blend pattern.
What “working” looks like
IGF-1 rises (pull at 8 weeks to confirm on-target effect). Body composition shifts (modest lean-mass support, visceral fat redistribution) typically lag 2-3 months. Sleep quality improves before composition does. Recovery from training improves modestly as you ramp back up.
Decision criteria
At week 12-16: re-check IGF-1, fasting glucose, A1c. If IGF-1 rose appropriately + body composition shifted + sleep improved: continue with cycling (8-12 weeks on, 4-8 weeks off). If IGF-1 didn't move: troubleshoot reconstitution + timing (meal-proximity insulin blunting is the most common issue). Long-term continuous GH-secretagogue use is not well-characterized for safety — cycle off rather than running indefinitely.
Labs to pull
- IGF-1 (on-target marker for GH-axis stimulation)
- Fasting glucose + A1c (GH is counter-regulatory to insulin)
- TSH + free T4 (re-confirm thyroid stable before continuing)

Cautions

BREASTFEEDING IS A HARD GATE for Phase 2 (BPC-157) and Phase 3 (CJC/Ipa). Neither peptide has human breastfeeding safety data; transfer to breast milk and effects on a nursing infant have not been characterized. If you are breastfeeding (including any combination of breast + formula feeding), Phase 2 and Phase 3 are off-table — defer until weaning is FULLY complete. Phase 1 (B12 + B-complex) is safe during breastfeeding.
Postpartum hemorrhage or any unexplained ongoing bleeding is a MEDICAL EMERGENCY — call your OB-GYN immediately, do NOT start any peptide protocol while bleeding is unresolved. Hemorrhage history (significant blood loss at delivery) warrants ferritin + iron studies before assuming peptides are the right adjunct — iron repletion is often the higher-leverage intervention.
Postpartum depression is common (~10-20% of births) and NOT what this protocol treats. PPD has effective standard treatment — therapy + breastfeeding-compatible SSRI (sertraline is first-line). If you have low mood, anhedonia, intrusive thoughts about harm to yourself or the baby, or feel persistently unable to bond with your baby, the answer is your OB-GYN or a perinatal mental health clinician, NOT this protocol. If you have any active suicidal ideation, call or text 988 (US Suicide & Crisis Lifeline) — get crisis care immediately.
Postpartum thyroiditis (~5-10% of births) often presents with overlapping symptoms — fatigue, weight changes, mood shifts, hair loss — that may be misattributed to 'I just need more energy.' Pull TSH + free T4 + TPO antibodies before assuming peptides will fix it; thyroid replacement (if hypothyroid phase) or beta-blocker / monitoring (if hyperthyroid phase) is the right intervention.
C-section healing must be COMPLETE before Phase 2 (typically 6-8 weeks minimum, longer for complicated healing) — and you must be post-weaning. BPC near a healing surgical wound is not the indication for early-postpartum tissue repair; let the wound heal under standard care first.
Active infection — mastitis, endometritis, wound infection — is a contraindication for adding peptides; treat the infection with standard care first.
Pelvic floor concerns (incontinence, prolapse, painful intercourse) are NOT addressed by this protocol. Pelvic floor PT is the high-leverage intervention; BPC tissue support is at most a modest adjunct. Do not substitute peptides for proper pelvic floor evaluation.
Pediatric exclusion. This protocol is for adults 18+.

Discuss with your clinician

OB-GYN follow-up at 6 weeks postpartum (or earlier if symptoms) is mandatory — that is the clinical gatekeeper for wound healing, contraception decisions, pelvic floor screening, depression screening, and thyroid screening. This protocol does not replace that visit.
Postpartum depression screening: ask explicitly. Many postpartum users normalize symptoms that meet diagnostic criteria. The Edinburgh Postnatal Depression Scale (EPDS) is a standard screening tool; your OB-GYN should administer it but you can also self-screen and bring concerns up.
Order Phase 1 labs at 6-8 weeks postpartum: B12, folate, CBC + ferritin + iron studies, TSH + free T4 + TPO antibodies, 25-OH vitamin D. These are the most-common deficiency presentations in postpartum users.
If you had postpartum hemorrhage at delivery (>500 mL vaginal, >1000 mL C-section), iron studies + ferritin are non-optional — significant iron deficiency may need IV iron repletion rather than oral supplementation.
Before any Phase 2/3 transition (after weaning): confirm you are fully weaned (no nursing, no pumping, milk supply has dried up). Discuss with OB-GYN whether your hormonal status (cycle return, postpartum hormone normalization) is complete before adding GH-axis stimulation.
Pelvic floor PT referral if you have any of: incontinence (urinary or fecal), pelvic heaviness, painful intercourse, diastasis recti not resolving. This is high-leverage; do not substitute peptides for proper pelvic floor evaluation.

Evidence summary

Tier 3 protocol overall. Phase 1 (B12 + B-complex) is Tier 1-2 for the deficiency-replacement indications most postpartum users actually have (this is among the most evidence-based supplementation use cases — parenteral B-complex is standard of care for Wernicke's encephalopathy, post-bariatric malabsorption, hyperemesis gravidarum). Postpartum cofactor support sits in a similar high-confidence space. Phase 2 (BPC-157) is Tier 3 — rodent tissue-repair evidence is consistent; human evidence is small uncontrolled case series; the postpartum-specific use case has no published clinical data. Phase 3 (CJC/Ipa) is Tier 2 for GH/IGF-1 axis restoration on component PK/PD data; Tier 3 for body-composition outcomes. The protocol's weakest link is Phase 2-3 in the post-weaning window; the strongest is Phase 1 cofactor work during breastfeeding.

Components (4)

B12 (Methylcobalamin)Vitamin (methylcobalamin)
B-Complex (Injectable)Vitamin (B-complex)
BPC-157Gastric pentadecapeptide
CJC-1295 / IpamorelinBlend

Often combined with

Energy & Vitality
B12 + B-complex overlap with Energy Phase 1. If you're running both protocols (e.g., postpartum cofactor restoration + continued energy support beyond the postpartum window), do NOT double-dose — single B12 weekly + B-complex monthly covers both surfaces.
Recovery from Injury
BPC-157 overlap (post-weaning Phase 2). If active injury overlaps with the post-weaning recovery window (training-related, accident-related), do NOT double-dose BPC — Recovery from Injury uses 500mcg 2x daily for active injury; that dose covers both indications.

Ready to add this protocol to your stack?

Phase 1 entries start today; later phases are future-dated and ready to edit.